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adult. Withdrawal the acute phase serum, we ﬁnished the blood
routine, hepatic function and IgM antibody test. In adult group
we detected the T lymphocytes sub-type using ﬂow cytometry.
Results: 216 patients’ infectious spectrum was like a spindle,
the infants and adults parts of the infectious spectrum reach a
total of 81.48%. The clinical symptoms remain relatively typical.
Different groups showed their own clinical manifestations, The
major features of the infants group are cough and Korotkoff
plaques, in this group, the MV-IgM positive rate is the highest,
83.67% of the infants have complications. The subjects of the
children group showed the major symptoms as catarrhal, 70% of
which with complications. Hepatic function in the adult group is
signiﬁcantly abnormal. In our 78 cases adult patients, the FCM
results suggest CD4 cell count and CD4/CD8 decreased signiﬁ-
cantly, and CD8 increased signiﬁcantly, also CD4 + CD45RA + was
signiﬁcantly lower than control (p<0.05), and CD8 + CD45RO +
was signiﬁcantly higher than control group (p<0.05).
Conclusion: The use of measles vaccine greatly change its infec-
tious spectrum. The emergence of new clinical characteristics
give us challenges for its prevention and control. At the same
time, further study of the measles infectious cellular immunity
mechanism still needed.
PP-183 Prevalence of pneumonia cases during the Hajj
season
Atif Asghar*,1, Ahmad Ashshi 1, Aiman Momenah1, Tariq Zafar 1,
Esam Azhar2, Syed Bukhari 3. 1Umm Al-Qura University; 2King
Abdulaziz University; 3Herra Genaral Hospital
Background: The congregation of so many people during Hajj
seasons from different parts of the world in unavoidably over-
crowded conditions within a conﬁned area for a deﬁned period of
time presents many public health challenges, and health risks are
greatly increased. One of the main health problems correlated
with Hajj crowding is pneumonia due to its ease of transmission
by air droplets.
Method: A total of 92 suspected patients with pneumonia from
the three main tertiary hospitals in Makkah were investigated
during the 2005 Hajj season. Sputum and serum samples were
collected and investigated for possible presence of typical or
atypical causative agents using the standard identiﬁcation tech-
niques.
Results: Clinically, most of the patients came with typical pneu-
monia symptoms. More than 60% of the patients were above 60
years old and 58% were men. The most frequent isolates were
Candida spp, (27%) followed by Pseudomonas aeruginosa (20.7%)
and Legionella pneumophila (14.1%). Interestingly, more than
causative pathogen were isolated in 15 patients (16.3%). A 55%
of patients were diabetic.
Conclusion: Clinicians should be aware that typical pneumonia
treatment regimes may not work well during the Hajj season
due to the wide variety of isolated organisms. This necessitates
taking a sputum sample before starting treatment for identiﬁ-
cation and sensitivity testing. Since most of the patients are
above 60 years, a special concern should be given to this age
group which include; immunization, avoiding crowding and using
a facial masks to reduce the chance of infection.
PP-184 Clinical characteristics and detection of human
bocavirus in hospitalized children with acute
lower respiratory tract infection in China
Guo-cheng Zhang*, Xue-houg Zhang, Xiao-jing Nie,
Dong-liang Xu, Biao Li. Department of Pediatrics, Xijing
Hospital, Fourth Military Medical University, Xi’an, China
Background: The newly identiﬁed human bocavirus (HBoV), a
member of the Parvoviridae family, has been associated to low
respiratory tract infections in young children.
Objective: To analyze clinical characteristics of HBoV infection
through detection of HBoV DNA in Sputum and serum in pediatric
patients with acute lower respiratory tract infection (ALRTI) in
Xi’an, China.
Methods: Sputum and acute-phase serum were collected from
228 children less than 14 years old admitted for ALRTI between
January 2008 and January 2009 at the Department of paediatrics,
of Xijing Hospital. sputum was used for HBoV DNA extraction and
detection of common respiratory viruses. In addition, Sputum and
acute-phase and convalescent-phase serum samples of children
with positive hBoV DNA in Sputum were also tested for HBoV DNA
and PVB19 DNA if they were obtained. Clinical characteristics of
HBoV infection were analyzed. The HBoV infections with other
respiratory viruses and PVB19 were also analyzed. PCR products
with expected molecular mass was selected for DNA sequencing
and were compared with the sequences of HBoV in the GenBank
with clustalW software.
Results: HBoV was found in 14 (6.1%) samples. Infections with
HBoV were most occurred in the winter and spring months.
73.3% of patients with HBoV infection were aged 6 months to
3-year-old.In common with other respiratory viruses infection,
clinical manifestations included cough, fever, wheezing, diar-
rhea, hypoxia and length of stay. In 6 (42.9%) of the HBoV
positive children, co-infections with other respiratory viruses
were present. HBoV infections with other respiratory viruses
and PVB19 were clinically similar to single infections except the
wheezing, hypoxia and length of stay. The sequenced product
(291bp) shared high nucleotide sequence homology (99.6%) with
the prototype Stockholm 2 (st2, No. DQ00496) and two Beijing
strains (No. DQ988934.2 and No. DQ988933.1) when compared
with their sequences. Both HBoV DNA and PVB19 DNA were not
detected in either sputum or the acute- and convalescent-phase
serum of 14 patients whose sputum was positive for HBoV as
determined by PCR.
Conclusions: HBoV is found in sputum of hospitalized for ALRTI in
14 children, children with HBoV infections with other respiratory
viruses and PVB19 were prone to have wheezing, hypoxia and
more days hospitalized.
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PP-185 A health systems approach to managing and
integrating STI services in Cape Town, South
Africa
Vera Scott, Feroza Amien*. University of the Western Cape
Background: In Cape Town, a metropolitan area in South Africa,
programme and facility managers are committed to improving
the effectiveness and integration of the STI programme. This is
achieved with annual evaluations.
Methods: A standardized evaluation tool has been used: a review
of routine information; a facility manager interview to assess
availability of services and staff training; an inspection checklist
to assess whether consulting rooms are appropriately equipped
to support quality syndromic management consultations; a folder
review to assess quality and integration of client care. Audit
teams are made up of facility and programme managers.
Results: In October 2008, 146 health facilities and all their facil-
ity managers participated, and 1199 STI folders were reviewed
(see Table 1, p. S99).
Conclusion: These results provide primary level facility man-
agers with useful information to strengthen programme delivery
in facilities, the key level of implementation. There are still
missed opportunities in targeting STI consultations for further
HIV prevention work.
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PP-186 Seroepidemiology of Infection with herpes
simplex virus type 2 (HSV2) among asymptomatic
students attending Islamic Azad University of
Kazeroun, Southwest Iran
Daryoush Tayyebi *,1, Mojgan Tabatabaee1, Marjan Rahsaz2.
1Islamic Azad University, Kazeroun Branch; 2Shiraz
Transplantation Research Center
Background: Herpes simplex virus (HSV) infections are among
the most common infectious diseases in humans. The prevalence
of herpes simplex viruse type 2 (HSV-2) varies widely across
the world. Most HSV-2 infections are consequently expected to
occur after the onset of sexual activity. Genital herpes is a cause
of morbidity and increases the risk of HIV acquisition, due to
disruption of mucosal membranes.
Methods: In our descriptive study, the study group comprised
270 students with the average age of 22.2. At the beginning,
demographic data were recorded by using a questionnaire. For
serological studies 5 ml of blood sample was collected and the
serum was isolated by centrifugation. Enzyme linked immunosor-
bent assay (ELISA) was used for determination of immunoglobulin
G (IgG) antibody titer to the HSV-2. Finally the results were
analyzed by statistical methods.
Results: Overall, HSV-2-IgG antibody was positive in 63 persons
(23.3%) out of 270 subjects and they had a previous infection.
We can ﬁnd a signiﬁcant difference in prevalence between
men and women but didn’t ﬁnd any signiﬁcant relationship be-
tween students with different ﬁeld of study and their residence
(p>0.05).
Conclusion: The overall incidence of HSV-1infection in this study
was 23.3%.
Certainly information on age- and gender-speciﬁc prevalence of
HSV-2 infection is crucial to guide herpes control strategies and
prevention of HSV-2 infection should target individuals before
they become sexually active.
PP-187 Safety and immunogenicity of a HPV-16/18
AS04-adjuvanted vaccine in a phase I study in
Chinese females
Fengcai Zhu*,1, Changgui Li 2, Hongxing Pan1, Yiju Zhang1,
Dan Bi 3, Haiwen Tang3, Sanjoy Datta3. 1Jiangsu Province CDC;
2National Institute for the Control of Pharmaceutical and
Biological Products (NICPBP); 3GlaxoSmithKline Biologicals
Introduction: With age-adjusted incidence and mortality rates
up to 81/100,000 and 30/100,000 women respectively in certain
parts, cervical cancer represents a major public health challenge
in China. Immunization against oncogenic HPV has been found to
be highly efﬁcacious to prevent precancerous cervical lesions in
global vaccine studies. A Phase I study in Jiangsu Province, China,
provides the ﬁrst HPV vaccination data in local Chinese women.
Methods: In an open-label study, 30 healthy Chinese females
aged 15-45 years were, after appropriate informed consent,
recruited and vaccinated with HPV-16/18 AS04-adjuvanted vac-
cine (Cervarix™, GlaxoSmithKline Biologicals) in a 0-1-6 month
schedule. Follow-up until Month 7 was conducted for serious
adverse events (SAE), other adverse events and reactogenicity,
with data recorded by patient diary cards. Blood draws on enroll-
ment and at Month 7 enabled immunogenicity assessments for
anti-HPV-16/18.
Results: 29 subjects completed the study. One subject dropped
out due to a SAE (breast cancer) – later assessed to be unrelated
to vaccination by the investigators. The most commonly reported
solicited local symptom was pain at injection site after 65.2% of
doses (only 4.5% were considered severe) and the most commonly
reported solicited general symptoms were fatigue, headache and
myalgia (after 19.1%, 13.5% and 11.2% of doses respectively).
4 subjects reported at least one unsolicited symptom. 100%
seroconversion with high GMTs were observed in women who
completed the study at Month 7: anti-HPV-16=6187.9EL.U/ml
(CI: 4767.9, 8030.9); anti-HPV-18=2538.4 EL.U/ml (CI: 1854.0,
3475.3).
